Parathyroid hormone as a marker for metabolic bone disease of prematurity
نویسندگان
چکیده
منابع مشابه
Calcitriol treatment in metabolic bone disease of prematurity with elevated parathyroid hormone: A preliminary study
Objective To describe the association of calcitriol treatment with the change in parathyroid hormone (PTH) and biochemical markers of bone disease in infants with metabolic bone disease of prematurity (MBD) and secondary hyperparathyroidism. Study design This retrospective chart review examined serum intact PTH, serum calcium (Ca), serum phosphorus (P), serum alkaline phosphatase (APA), urine...
متن کاملMetabolic bone disease of prematurity☆
Metabolic bone disease (MBD) of prematurity remains a significant problem for preterm, chronically ill neonates. The definition and recommendations for screening and treatment of MBD vary in the literature. A recent American Academy of Pediatrics Consensus Statement may help close the gap in institutional variation, but evidence based practice guidelines remain obscure due to lack of normative ...
متن کاملMetabolic Bone Disease of Prematurity: Report of Four Cases
Osteopenia of prematurity has become a common problem recently because of improved survival rates of infants with very low birth weight (VLBW). The incidence of neonatal osteopenia is inversely correlated with gestational age and birth weight. Herein, we present four cases of preterm osteopenia that were referred to the pediatric endocrinology outpatient clinic with diverse clinical and laborat...
متن کاملParathyroid hormone: critical bridge between bone metabolism and cardiovascular disease.
arathyroid hormone (PTH) is a principal regulator of calcium balance in physiological and pathological conditions associated with cardiovascular disorders and plays a major physiological role in bone homeostasis (Figure 1). PTH systemically controls bone remodeling by modulating the bone marrow microenvironment and regulating osteogenic signaling pathways. 1 PTH and its related peptide can have...
متن کاملMetabolic Bone Disease of Prematurity: A Review of Minerals Supplementation and Disease Monitoring
Metabolic bone disease is a frequent condition in very low birth weight (VLBW) infants. In order to prevent the disease, the provision of high amount of calcium and phosphate in parenteral nutrition solutions and during transition to the full enteral feedings is crucial. Current practice supports early aggressive mineral supplementation. In this review, we will discuss data from the recent lite...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Perinatology
سال: 2014
ISSN: 0743-8346,1476-5543
DOI: 10.1038/jp.2014.97